Form 4: Ventas Director Marguerite M. Nader Acquires Additional Shares Through Dividend Equivalents

Director Marguerite M. Nader acquired additional Ventas, Inc. shares through dividend equivalents under the company's Non-Employee Directors' Equity Award Deferral Program.

Summary

• On April 18, 2024, Marguerite M. Nader, a director of Ventas, Inc., acquired 41.668 shares of common stock.
• The acquisition was a result of dividend equivalents credited under the Ventas Non-Employee Directors' Equity Award Deferral Program.
• The price per share was $42.64, representing the closing price on the date of the grant.
• Following the transaction, Nader directly owns 14,372.936 shares of Ventas, Inc.
• Nader has a Power of Attorney designating Carey S. Roberts, Kevin Bohl, Kenneth Hagan, and Jose Torres to file relevant forms with the SEC.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (director share acquisition via dividend equivalents). It's neutral to slightly positive as it indicates director's continued investment in the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It reflects the standard practice of compensating directors with equity and reinvesting dividends.

Comparison to Industry Standards

• Equity compensation and dividend reinvestment programs for directors are common practices among publicly traded REITs like Ventas, Inc.
• Similar programs are offered by competitors such as Welltower Inc. and Healthpeak Properties, Inc., allowing directors to accumulate shares over time.
• The specific terms of these programs, such as the dividend equivalent rate and vesting schedules, can vary among companies.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It may indirectly signal director confidence to shareholders.

Key Dates